BTG plc (LON:BTG – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 840 ($10.53) and traded as high as GBX 840 ($10.53). BTG shares last traded at GBX 840 ($10.53), with a volume of 271,742 shares.
BTG Price Performance
The stock has a market capitalization of £3.26 billion and a P/E ratio of 29.47. The company’s 50 day simple moving average is GBX 840 and its two-hundred day simple moving average is GBX 840.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Featured Stories
- Five stocks we like better than BTG
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Tesla Investors Continue to Profit From the Trump Trade
- Election Stocks: How Elections Affect the Stock Market
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- What is the Australian Securities Exchange (ASX)
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
